BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29182583)

  • 1. trans-Double Bond-Containing Liposomes as Potential Carriers for Drug Delivery.
    Giacometti G; Marini M; Papadopoulos K; Ferreri C; Chatgilialoglu C
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29182583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5-trans Isomer of Arachidonic Acid on Model Liposomal Membranes Studied by a Combined Simulation and Experimental Approach.
    Tremi I; Anagnostopoulos D; Spyratou E; Gkeka P; Georgakilas AG; Chatgilialoglu C; Cournia Z
    J Membr Biol; 2018 Jun; 251(3):475-489. PubMed ID: 29610947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regioselective cis-trans isomerization of arachidonic double bonds by thiyl radicals: the influence of phospholipid supramolecular organization.
    Ferreri C; Samadi A; Sassatelli F; Landi L; Chatgilialoglu C
    J Am Chem Soc; 2004 Feb; 126(4):1063-72. PubMed ID: 14746474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perifosine induced release of contents of trans cell-barrier transport efficient liposomes.
    Koklic T
    Chem Phys Lipids; 2014 Oct; 183():50-9. PubMed ID: 24863642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and simulation of the liposomal model by using a coarse-grained molecular dynamics approach towards drug delivery goals.
    Parchekani J; Allahverdi A; Taghdir M; Naderi-Manesh H
    Sci Rep; 2022 Feb; 12(1):2371. PubMed ID: 35149771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence study of lipid-based DNA carriers properties: influence of cationic lipid chemical structure.
    Burel-Deschamps L; Mével M; Loizeau D; Ayadi F; Yaouanc JJ; Clément JC; Jaffrès PA; Giamarchi P
    J Fluoresc; 2008 Sep; 18(5):835-41. PubMed ID: 18224428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane lipidomics and the geometry of unsaturated fatty acids from biomimetic models to biological consequences.
    Ferreri C; Chatgilialoglu C
    Methods Mol Biol; 2009; 579():391-411. PubMed ID: 19763487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
    Hansen AH; Mouritsen OG; Arouri A
    Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and development of multi-walled carbon nanotube-liposome drug delivery platforms.
    Pippa N; Chronopoulos DD; Stellas D; Fernández-Pacheco R; Arenal R; Demetzos C; Tagmatarchis N
    Int J Pharm; 2017 Aug; 528(1-2):429-439. PubMed ID: 28627453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
    González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
    J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and pharmacokinetic characteristics of cationic liposomes.
    Yeeprae W; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Pharmazie; 2006 Feb; 61(2):102-5. PubMed ID: 16526555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein-encapsulation on thermal structural stability of liposome composed of glycosphingolipid/cholesterol/phospholipid.
    Hirai M; Sato S; Kimura R; Hagiwara Y; Kawai-Hirai R; Ohta N; Igarashi N; Shimizu N
    J Phys Chem B; 2015 Feb; 119(8):3398-406. PubMed ID: 25642599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of thiyl radical-catalyzed isomerization of unsaturated fatty acid residues in homogeneous solution and in liposomes.
    Sprinz H; Schwinn J; Naumov S; Brede O
    Biochim Biophys Acta; 2000 Jan; 1483(1):91-100. PubMed ID: 10601698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.